DCI : Salbutamol
SALBUNHAL is bronchodilator. The mechanism action of SALBUNHAL is related to the specific agonist property of salbutamol for beta-2 receptors of bronchial smooth muscle. The agonist-receptor complex training induced activation cascade of cytoplasmic proteins resulting in rapid relaxation, in a few minutes (5 à 20 minutes after inhalation), of bronchial smooth muscle.
Therapeutic indications :
- Symptomatic treatment of the asthma attack.
- Symptomatic treatment of exacerbations during asthmatic disease or of chronic obstructive bronchitis when there is reversible component.
- Prevention of exercise-induced asthma.